Monika Dzierżak‐Mietła

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 154 citations · Full text

Medicine, Hematology, Immunology +17

Role of Donor Activating KIR–HLA Ligand–Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients

Jacek Nowak, Katarzyna Kościńska, Renata Mika‐Witkowska et al. · Biology of Blood and Marrow Transplantation · 2015 · 34 citations · Full text

Life Sciences, Hematology, Immunology +15

Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation

Mirosław Markiewicz, Monika Dzierżak‐Mietła, Andrzej Frankiewicz et al. · Supportive Care in Cancer · 2012 · 33 citations · Full text

Dentistry, Oral Health Sciences, Oral Medicine +17

Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Multicenter Analysis by the Polish Adult Leukemia Group

Mirosław Markiewicz, Joanna Drozd‐Sokołowska, Przemysław Biecek et al. · Biology of Blood and Marrow Transplantation · 2020 · 33 citations · Full text

Medicine, Hematology, Cell Therapy +13

Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients

Jacek Nowak, Katarzyna Kościńska, Renata Mika‐Witkowska et al. · American Journal of Hematology · 2014 · 27 citations · Full text

Life Sciences, Hematology, Immunology +17